台股 » 個股 » 易威 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

易威

(1799)
  • 股價
    93.0
  • 漲跌
    ▲6.7
  • 漲幅
    +7.76%
  • 成交量
    988
  • 產業
    上櫃 生技醫療類股
  • 65人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
易威 (1799)籌碼相關-元富-信義 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

元富-信義 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/04/2200.00264.5064.50-2253-0.79%
2024/02/2100.00047.2047.000182-0.02%
2024/02/20248.2000.0048.3021801.11%
2024/02/1900.00152.2052.50-1184-0.54%
2024/02/1600.000.352.0052.00-0.3183-0.17%
2024/02/150.155.00552.9255.50-4.9177-2.77%
2024/02/05649.9900.0050.5061643.65%
2023/06/1900.00221.8021.70-2104-1.92%
2023/06/0700.00223.2023.30-2140-1.42%
2023/06/06523.7900.0024.1051393.58%
2023/06/05925.0900.0024.8091376.56%
2023/04/1300.000.119.9020.05-0.197-0.13%
2023/03/3100.000.319.6019.95-0.392-0.30%
2023/03/30419.5600.0019.304914.35%
2023/03/2800.00121.5022.40-178-1.27%
2023/03/27822.1000.0021.7087510.57%
2023/03/15819.6200.0019.5084517.50%
2023/02/1300.000.715.2015.20-0.712-5.67%
2022/09/1500.00310.0010.20-3112-2.67%
2022/05/2600.00113.6513.65-1143-0.70%
2022/04/2700.00114.9514.95-1132-0.75%
2022/04/2100.00315.0015.00-3116-2.58%
2022/04/18516.9500.0016.955925.42%
2021/08/2400.00415.6015.60-4137-2.91%
2021/05/31117.1000.0017.0014840.21%
2021/05/20116.6000.0016.6015500.18%
2021/03/2900.00216.5516.50-2271-0.74%
2021/03/1700.00516.4016.40-5269-1.85%
2021/03/02218.4800.0017.4022560.78%
2021/02/2600.00318.1518.15-3230-1.30%
2021/02/25216.6500.0016.5021971.01%
2021/02/24216.8800.0016.8521971.01%
2021/02/23417.7100.0017.4541932.07%
2020/11/3000.00218.7018.85-2376-0.53%
2020/10/1400.00215.3515.40-2671-0.30%
2020/09/2400.00417.0017.20-41,328-0.30%
2020/08/20421.00419.9419.7002,1210.00%
2020/08/19421.7000.0021.8042,1280.19%
2020/07/28124.1500.0023.4012,2650.04%
2020/07/24127.0000.0027.0012,2360.04%
2020/07/15130.70331.3730.80-21,983-0.10%
2020/07/14530.41332.3729.6021,9070.10%
2020/07/13530.9000.0031.5551,7930.28%
2020/07/10327.9000.0028.7031,6660.18%
2020/06/0300.00117.3517.60-1963-0.10%
2020/06/01117.9000.0017.7019680.10%
2020/05/2100.00216.3016.30-2830-0.24%
2020/03/04215.0000.0014.9524590.44%
2020/03/0200.00214.1514.60-2397-0.50%
2020/02/26213.1500.0014.0523210.62%
2019/07/2500.00511.5511.40-5146-3.42%
2019/07/23511.8000.0011.7551443.45%
2019/03/2200.00512.5512.55-5147-3.38%
2019/02/1800.00312.3512.35-3119-2.51%
2019/02/15312.7000.0012.6031172.56%
2019/01/1600.001012.9013.75-10105-9.47%
2019/01/141014.1000.0014.00109410.62%
2018/06/0500.00818.0618.05-8394-2.03%
2018/05/2400.00218.0018.00-2393-0.51%
2018/05/1800.00418.5018.25-4398-1.00%
2018/04/12722.3600.0022.0072492.81%
2018/04/11722.2100.0022.9072323.01%
易威慢性心臟衰竭用藥獲中國藥證 明年Q1底展開銷售Anue鉅亨-2023/10/30
美新行政令強化製藥在地化 易威、泰福-KY迎來新訂單Anue鉅亨-2022/09/20
〈易威法說〉策略轉型見成效 新藥、學名藥營收比重拚達7成Anue鉅亨-2021/12/17
易威 相關文章
易威 相關影音